EGFR controls bone development by negatively regulating mTOR-signaling during osteoblast differentiation.

about

Rapamycin rescues BMP mediated midline craniosynostosis phenotype through reduction of mTOR signaling in a mouse model

P2860

Q56262145-28E12F4C-43E7-480F-BFD6-2D61E3C6E88D

P2860

EGFR controls bone development by negatively regulating mTOR-signaling during osteoblast differentiation.

Item

http://www.wikidata.org/entity/Q55230047

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

EGFR controls bone development ...... ng osteoblast differentiation.

@en

EGFR controls bone development ...... ng osteoblast differentiation.

@nl

type

Item

label

EGFR controls bone development ...... ng osteoblast differentiation.

@en

EGFR controls bone development ...... ng osteoblast differentiation.

@nl

prefLabel

EGFR controls bone development ...... ng osteoblast differentiation.

@en

EGFR controls bone development ...... ng osteoblast differentiation.

@nl

P1476

EGFR controls bone development ...... ng osteoblast differentiation.

@en

P2093

Georg Schett

http://www.w3.org/2001/XMLSchema#string

Jan Tuckermann

http://www.w3.org/2001/XMLSchema#string

Karin Zwerina

http://www.w3.org/2001/XMLSchema#string

Maria Grazia Ruocco

http://www.w3.org/2001/XMLSchema#string

Markus Linder

http://www.w3.org/2001/XMLSchema#string

Martin Holcmann

http://www.w3.org/2001/XMLSchema#string

P2860

Mice humanised for the EGF receptor display hypomorphic phenotypes in skin, bone and heart

Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype

Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee

Tsc2 is a molecular checkpoint controlling osteoblast development and glucose homeostasis

Epidermal growth factor receptor regulates aberrant expression of insulin-like growth factor-binding protein 3

EGFR has a tumour-promoting role in liver macrophages during hepatocellular carcinoma formation.

The role of Pax-1 in axial skeleton development.

Epidermal growth factor receptor (EGFR) signaling promotes proliferation and survival in osteoprogenitors by increasing early growth response 2 (EGR2) expression

The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities.

Reaching a genetic and molecular understanding of skeletal development.

P2888

s41418-017-0054-7

P304

1094-1106

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41418-017-0054-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-02-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1101032311

http://www.w3.org/2001/XMLSchema#string

P698

29445126

http://www.w3.org/2001/XMLSchema#string

P921

osteoblast

P932

5988706

http://www.w3.org/2001/XMLSchema#string

EGFR controls bone development by negatively regulating mTOR-signaling during osteoblast differentiation.

about

P2860

P2860

EGFR controls bone development by negatively regulating mTOR-signaling during osteoblast differentiation.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P932